Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Novartis
McKinsey
Baxter
Deloitte
Federal Trade Commission
Argus Health
Colorcon
Daiichi Sankyo
Cipla

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,445,606

« Back to Dashboard

Summary for Patent: 5,445,606
Title: Indicator for iontophoresis system
Abstract:Apparatus (11) for delivery of a medicament, drug or other therapeutic agent transdermally to a body by iontophoresis is provided. The apparatus (11) provides a means (13) for measuring and displaying the cumulative amount of the medicament delivered to the body by monitoring the amount of a metal, initially present at the anode (45), that is transferred to the cathode (41) in a subsidiary electrolyte cell (47) through which the drive current for the apparatus (11) passes. Optionally, the apparatus also provides a plurality of light emitting devices (63-1) that display a measure of the cumulative amount of medicament delivered, by use of visually distinguishable light colors or by use of binary encoding in the light display.
Inventor(s): Haak; Ronald P. (San Jose, CA), Theeuwes; Felix (Los Altos, CA), Roe; David K. (Portland, OR)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:08/069,061
Patent Claim Types:
see list of patent claims
Device; Formulation; Delivery;

Drugs Protected by US Patent 5,445,606

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,445,606

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 155348 ➤ Sign Up
Australia 3249993 ➤ Sign Up
Australia 659269 ➤ Sign Up
Canada 2121591 ➤ Sign Up
Germany 69220964 ➤ Sign Up
European Patent Office 0616545 ➤ Sign Up
Finland 942755 ➤ Sign Up
Japan 3406315 ➤ Sign Up
Japan H07501962 ➤ Sign Up
South Korea 100222281 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Chinese Patent Office
Citi
Johnson and Johnson
Cerilliant
US Army
Cantor Fitzgerald
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot